Tag: #Global Trends

Strategic site expansion in Brooklyn IGC Pharma has officially added Integrative Clinical Trials, located in Brooklyn, New York, as a... Read more

AI-driven operational model Mendra, a San Francisco-based biotechnology startup, has officially emerged from stealth after securing $82 million in a... Read more

Expansion of treatment indications in China On January 22, 2026, China’s National Medical Products Administration (NMPA) officially approved Enhertu (trastuzumab... Read more

Major financial milestone via Series D1 funding On January 23, 2026, Corxel Pharmaceuticals announced the closure of a $287 million... Read more

Termination of relations and resource withdrawal On January 23, the U.S. Department of Health and Human Services (HHS) announced the... Read more

The U.S. Food and Drug Administration (FDA) has issued a draft guidance for the industry, proposing the use of Minimal... Read more

The European Commission (EC) has granted marketing authorization for Otsuka’s Dawnzera (donidalorsen) for the routine prevention of recurrent attacks in... Read more

China has transitioned from having one of the world's most sluggish drug approval systems to one of the fastest. This... Read more

Medical technology leaders BD (Becton, Dickinson and Company) and Ypsomed have expanded their ongoing collaboration by introducing a new 5.5mL... Read more